Back to

Virginia

Biologics Compliance Guide for Clinics in Virginia

Learn the essential compliance steps to confidently offer biologics in Virginia. This guide covers state and FDA regulations, patient consent, and best practices to help you establish compliant stem cell therapy services.

1. Summary

This guide provides a structured overview for clinics and practitioners in Virginia looking to offer biologic treatments, particularly stem cell therapy. It includes federal and state regulatory guidance, patient consent requirements, and best practices to help ensure compliance.

2. FDA Compliance

In addition to FDA regulations, Virginia has state-specific requirements for administering biologics. Practitioners can refer to the Virginia Department of Health Professions for regulations regarding biologics and stem cell therapies: Virginia Department of Health Professions. The state’s guidelines are essential for ensuring compliance at the state level and cover licensing and professional standards for administering therapies.

3. Virginia State Regulations

California enforces additional regulations through the California Department of Public Health (CDPH), with oversight on biologics that may involve stem cell and tissue-based therapies. Clinics are encouraged to review state-specific guidelines for stem cell treatments to ensure compliance with local standards, including patient safety and ethical administration practices.

4. Provider Qualifications

In Virginia, only licensed medical professionals, such as physicians MDs or DOs, may administer stem cell and biologic treatments. Practitioners should meet the requirements set by the Virginia Board of Medicine, which include licensure verification, scope of practice, and continuing education. For more details, visit Virginia Board of Medicine.

5. Patient Informed Consent

Providers must obtain informed consent from patients before administering biologic treatments. Informed consent should include:

• A clear explanation of the treatment’s experimental nature, as some biologic therapies are not FDA-approved.
  
• Discussion of potential benefits and risks, with disclaimers that highlight the potential for unknown or limited efficacy.
  
• A description of alternative treatment options and the voluntary nature of the treatment.
  

6. Additional Compliance Areas

Virginia clinics should establish protocols to ensure patient safety and treatment efficacy. This includes screening procedures, risk assessment, and post-treatment follow-up requirements.

Implementing SOPs that detail every step of the patient care process, from initial assessment to post-treatment care, helps maintain high standards and ensures consistency in patient outcomes.

Clinics offering biologic therapies should carry adequate medical liability insurance, which may differ based on the specific therapies offered. Consult with a healthcare insurance provider for coverage recommendations tailored to biologics and stem cell therapy.

All marketing materials should comply with Virginia’s advertising regulations for medical practices. Avoid any claims of guaranteed success or cure for experimental treatments, and clearly disclose the investigational nature of certain therapies.

This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in Virginia. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.